Oncology & Hematology Coding Alert
Correction:
Taxotere and Gleevec
Published on Sat Jan 22, 2005
The article "Injection Code Smarts Sharpen Chemo Claims" in the November 2004 issue of Oncology Coding Alert contained an example of a physician subcutaneously delivering 40 milligrams of the anti-cancer drug Taxotere. However, Taxotere cannot be delivered subcutaneously.
In the same issue, "If Diagnosis Is Already Known, Don't Report E/M Service" proffered the example of a leukemia patient who undergoes regular chemotherapy injection treatments of Gleevec. The drug Gleevec is a tablet and cannot be given via injection.
Other Articles in this issue of
Oncology & Hematology Coding Alert
- Add Your Fractions Correctly to Avoid Fractured Claims
Be sure oncologist delivers three or more fractions before using 77427 If you don't know [...] - You Be the Coder:
What Constitutes a Fraction of Care?
Question: I am an experienced coder in other disciplines, but I just began working for [...] - Are Your Denial Records Electronic, Paper ... or Both?
J code quandary led one office on a high-tech quest If your practice received a [...] - Put Time on Your Side With E/M Coding
Increase your level of service with concise time documentation A thorough knowledge of time components [...] - Correction:
Taxotere and Gleevec
The article "Injection Code Smarts Sharpen Chemo Claims" in the November 2004 issue of Oncology [...] - Reader Questions:
Appeal Need: All the Evidence You Can Find
Question: When our office files an appeal, we usually think that we should be including [...] - Reader Questions:
Nasal Endoscopy Requires Accurate ICD-9 Coding
Question: A patient reported to our office last week for a nasal endoscopy. When does [...] - Reader Questions:
Biopsy/Aspirations May Need G Code for Medicare
Question: I have heard that there is a new G code for use with some [...]
View All
